Wikipedia -WSS

Wikipedia

author：focus 2025-08-11 07:58:59 - browse：54

Dozens of sickle cells in a whirlpool — coverage from STAT — Adobe

Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, each annotated with — from a business standpoint — their best and worst attributes.

The document was supposed to help Novak, then the chief executive of CRISPR Therapeutics, navigate a pressing quandary. His company, along with two others, were founded to commercialize the new revolutionary gene-editing tool CRISPR-Cas9, which promised to cure numerous genetic diseases. But which should they target first? What was the best proof-of-concept?

“We looked at anything and everything,” said Novak, who stepped down as CEO in 2017 but remained on the board until this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Hospitals consider fixing cancer drug shortages on their own

WSS

Anavex keeps shifting the goalposts in its clinical trials

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

New weight loss drugs vying to be the next Wegovy or Mounjaro

For Cytokinetics, FDA rejection of heart drug would help, not hinder

NIH trials fail to test meaningful long Covid therapies, experts say

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

explore

Wikipedia

hotspot

Walensky prepares to leave CDC — and Congress — behind

WATCH: Why do bright lights make us see spots?

Jerome Adams on the need for new antivirals for Covid

Generate Biomedicines machine learning biotech raises $273M

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Hospitals consider fixing cancer drug shortages on their own

DIEP, the 'gold standard' of breast reconstruction, is under threat

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Trump demands the U.S. pay no more for drugs than other countries … again

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

knowledge

Long Covid needs a new name — and a new frame

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Acelyrin, a rare IPO success, stumbles in its first big test

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Diverse clinical trials: Why aren’t we there yet?

Pig kidney works a record two months in donated body

focus

hotspot

focus

leisure time